The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.

Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company ...

On Tuesday, Wojcicki announced the new additions to 23andMe’s board: Andre Fernandez, a former CFO at WeWork, Inc., and NCR ...

Genetic testing firm 23andMe said on Monday it is reducing about 40 per cent, or 200 employees, from its workforce and ...

Andre Fernandez, Jim Frankola and Mark Jensen will join the company's CEO Anne Wojcicki on the board. 23andMe appointed three ...

Me said it appointed three new independent directors to its board on Monday. All seven of 23andMe's previous directors ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...

SUNNYVALE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), a leading ...

Anne Wojcicki has blamed 23andMe’s struggles ... winding down its internal drug development team, and is seeking partners to continue testing the two drug candidates it brought to early-stage ...

Anne Wojcicki’s net worth is estimated at around ... In 1999, she joined Ardley Partners as a healthcare investment analyst and worked at the company for one year. She then worked as a ...

Sales for the Atlanta-based company improved 6.6 percent to $40.22 billion, topping the $39.31 billion that analysts ...

That actually happened last month to Anne Wojcicki ... the directors wrote in a public letter to Wojcicki in September. Roelof Botha, a managing partner of Sequoia Capital, and Neal Mohan ...